Cargando…

G-protein- and phosphodiesterase-dependent regulation of neutrophil migration by antithrombin III involving CXC-receptor 1

Detalles Bibliográficos
Autores principales:	Dunzendorfer, S, Rabensteiner, A, Kaneider, N, Römisch, J, Wiedermann, CJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332950/ http://dx.doi.org/10.1186/cc746

Ejemplares similares

Inhibition of neutrophil migration by the serpin antithrombin III
por: Dunzendorfer, S, et al.
Publicado: (2000)

Specific deactivation of monocyte and lymphocyte migration by antithrombin III
por: Reinisch, C, et al.
Publicado: (2001)

Distinct antithrombin III preparations deactivate IL-8-induced neutrophil chemotaxis with different potency
por: Kaneider, N, et al.
Publicado: (2001)

Syndecan-4 on human peripheral blood lymphocytes and monocytes mediates effects of antithrombin on chemotaxis
por: Kaneider, NC, et al.
Publicado: (2002)

Inhibition of proliferation and induction of differentiation of endothelial cells by antithrombin
por: Reinisch, CM, et al.
Publicado: (2002)

Lipopolysaccharides-induced interleukin-8 production is inhibited by antithrombin
por: Gray, E, et al.
Publicado: (2001)

Lipopolysaccharide induced procoagulant activity and cytokine production: influence of antithrombin
por: Gray, E, et al.
Publicado: (2000)

Effect of antithrombin III (AT) on lipopolysaccharide (LPS)-induced production of tissue factor and interleukin-6 (IL-6) by human umbilical vein endothelial cells (HUVECs), mononuclear cells (MNCs) and whole blood
por: Souter, PJ, et al.
Publicado: (1999)

Inhibition of endotoxin-induced leukocyte/endothelial cell interaction by antithrombin III
por: Hoffmann, JN, et al.
Publicado: (1999)

Effect of antithrombin III on inflammatory immune response in patients with severe sepsis
por: Inthorn, D, et al.
Publicado: (1998)

Decreased Protein C, Protein S and Antithrombin III Levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei
por: Larosa, SP, et al.
Publicado: (2000)

Use of antithrombin III in cancer patients with sepsis complicated with disseminated intravascular coagulopathy
por: Polansky, M, et al.
Publicado: (1998)

Antithrombin III (AT III) prevents increased permeability and leukocyte adhesion in response to endotoxin (LPS) in the microcirculation of rat mesentery
por: Leithäuser, B, et al.
Publicado: (1999)

Direct antimicrobial activity of antithrombin?
por: Wiedermann, Christian J, et al.
Publicado: (2010)

Antibodies to beta(2)-glycoprotein I, prothrombin and antithrombin III as markers of the antiphospholipid syndrome severity
por: Zabek, J, et al.
Publicado: (2001)

Effects of Antithrombin III on body cavity effusions, fluid balance, colloid osmotic pressure and hemodynamics in porcine septic shock
por: Cobas Meyer, M, et al.
Publicado: (2000)

Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis
por: Kountchev, Jordan, et al.
Publicado: (2005)

Neutrophil-to-lymphocyte ratio, Factor VIII and Antithrombin III: inflammatory-clotting biomarkers in glioma
por: Koudriavtseva, Tatiana, et al.
Publicado: (2021)

Clinical review: Molecular mechanisms underlying the role of antithrombin in sepsis
por: Wiedermann, Christian J
Publicado: (2006)

The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation
por: Wengner, Antje M., et al.
Publicado: (2008)

Inhibition of HCV by the serpin antithrombin III
por: Asmal, Mohammed, et al.
Publicado: (2012)

Proper diagnosis of antithrombin III deficiency
por: Özdemir, Zehra Narlı, et al.
Publicado: (2017)

Antithrombin (AT) improves inflammation induced microcirculatory disturbance in rat mesentery
por: Leithäuser, B, et al.
Publicado: (2000)

Heparan Sulfate Proteoglycan–Involving Immunomodulation by Cathelicidin Antimicrobial Peptides LL-37 and PR-39
por: Kaneider, Nicole C., et al.
Publicado: (2007)

Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin
por: Djanani, Angela, et al.
Publicado: (2006)

Deficiency Of Antithrombin III (AT III) - Case Report and Review of the Literature
por: GĂMAN, AMELIA MARIA, et al.
Publicado: (2014)

Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory markers: a preliminary report
por: Giarratano, A, et al.
Publicado: (2000)

Antithrombin prevents proinflammatory activation via NFκ and MAPK signaling pathways
por: Oelschläger, C, et al.
Publicado: (2002)

Effect of unfractionated and low molecular weight heparin on microcirculatory antithrombin effects during endotoxemia
por: Hoffmann, JN, et al.
Publicado: (2002)

Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency
por: Nishimura, Yoshiyuki, et al.
Publicado: (2018)

Antithrombin III Protects Against Contrast-Induced Nephropathy
por: Lu, Zeyuan, et al.
Publicado: (2017)

Effect of Immobilized Antithrombin III on the Thromboresistance of Polycarbonate Urethane
por: Lukas, Karin, et al.
Publicado: (2017)

Antithrombin III concentrate therapy may have an efficacy in sepsis
por: Saito, N, et al.
Publicado: (2013)

SerpinC1/Antithrombin III in kidney-related diseases
por: Lu, Zeyuan, et al.
Publicado: (2017)

The Association between the Level of Antithrombin III and Mortality in Children with Sepsis
por: Lestari, Indah Nur, et al.
Publicado: (2019)

A meta-analysis of controlled trials of recombinant human activated protein C therapy in patients with sepsis
por: Wiedermann, Christian J, et al.
Publicado: (2005)

Marked reductions of protein C and antithrombin in post-trauma DIC have close relations with MODS and poor outcome
por: Gando, S, et al.
Publicado: (2002)

Cell-specific modulation of gastrointestinal NO-induced relaxation by phosphodiesterases
por: Groneberg, Dieter, et al.
Publicado: (2015)

Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase
por: Luengo-Gil, Ginés, et al.
Publicado: (2016)

The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
por: Korbecki, Jan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kecu09hgpb32tl33sru0ivjf1g